| MIR503HG | non small cell lung cancer | qRT-PCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 31983569 | 2020 |
| MIR503HG | non small cell lung cancer | qPCR, Western blot etc | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32184667 | 2020 |
| MIR503HG | cervical squamous cell carcinoma | qPCR, Western blot etc | L | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 32184661 | 2020 |
| MIR503HG | ovarian cancer | Dual-luciferase assay, qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 31907059 | 2020 |
| MIR503HG | non small cell lung cancer | qRT-PCR, Western Blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31858550 | 2019 |
| MIR503HG | triple negative breast cancer | RT-PCR, Western blotting etc. | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 31062436 | 2019 |
| MIR503HG | bladder cancer | qPCR, Western blot, in vitro knockdown, etc. | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | 30672010 | 2019 |
| MIR503HG | colorectal cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 31278965 | 2019 |
| MIR503HG | anaplastic large cell lymphoma | qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29758012 | 2018 |
| MIR503HG | choriocarcinoma | qPCR, Cell transfection, Cell cycle assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 27023770 | 2016 |
| MIR503HG | hepatocellular carcinoma | microarray, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29774077 | 2018 |
| MIR503HG | Tnbc | RNA immunoprecipitation;Flow Cytometry assay;RNA immunoprecipitation; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33869743 | 2021 |
| miR503HG | Hepatocellular carcinoma | Cell transfection;Cell transfection;Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 33046427 | 2021 |